Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Efficacy of Automated Tuina and Acupuncture for Treating Chronic Lower Back Pain

15. November 2026 aktualisiert von: Linda Zhong, Nanyang Technological University

Efficacy of Automated Tuina and Acupuncture for Treating Chronic Lower Back Pain: a Randomized Controlled Study

The goal of this clinical trial is to learn if adding automated robotic Tuina to acupuncture yields a better outcome than acupuncture alone in treating adults with chronic nonspecific low back pain. It will also learn about the safety of the automated robotic Tuina. The main questions it aims to answer are:

Does robotic Tuina and acupuncture reduces score of Visual Analogue Scale (VAS) more than acupuncture alone? Does it improve the sleep, quality of life, pain related impact of participants? Researchers will compare automated robotic Tuina and acupuncture to acupuncture alone if the combination works better to treat chronic nonspecific low back pain.

Participants will:

Receive weekly treatment of either automated robotic Tuina and acupuncture or acupuncture only for 6 sessions over 8 weeks.

Visit the clinic weekly for interventions and test. Wear a sleep tracker ring on the night before and night of treatment to sleep.

Studienübersicht

Status

Rekrutierung

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

Chronic nonspecific low back pain is a common condition that can affect daily activities and quality of life. Tuina is a traditional Chinese medicine manual therapy that may help relieve pain and improve function. Automated robotic Tuina may offer a more standardized approach to delivering this treatment.

This randomized controlled study aims to evaluate whether adding automated robotic Tuina to acupuncture provides additional benefits for adults with chronic nonspecific low back pain, compared with acupuncture alone.

A total of 56 participants aged 21 to 70 years are planned for recruitment across three study sites in Singapore. Participants will be randomly assigned in a 1:1 ratio to receive either acupuncture alone or acupuncture combined with automated robotic Tuina.

The primary outcome is low back pain intensity measured using a visual analogue scale (VAS). Secondary outcomes include physical disability, pain-related interference, quality of life, sleep-related measures and acceptance of robotic Tuina. Adverse events will also be monitored throughout the study.

The findings may help clarify the additional clinical benefit and safety of automated robotic Tuina when used alongside acupuncture for chronic nonspecific low back pain.

Studientyp

Interventionell

Einschreibung (Geschätzt)

56

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studieren Sie die Kontaktsicherung

Studienorte

      • Singapore, Singapur, 229469
        • Rekrutierung
        • Novahealth TCM Clinic
        • Kontakt:
          • Chin Ee Ho
          • Telefonnummer: +65 84130628
      • Singapore, Singapur, 637551

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

21 Jahre bis 70 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Adults aged 21 to 70 years.
  • At least one primary care visit for back pain within the past 3 to 12 months at either a Chinese medicine or Western medicine clinic.
  • Non-specific, uncomplicated low back pain, as specified in the study protocol.
  • Able to communicate and write in English and/or Chinese.

Exclusion Criteria:

  • Previous acupuncture for back pain within the past 3 months.
  • Low back pain lasting less than 3 months.
  • Mild symptoms, defined in the protocol as a score below 5 on a 0 to 10 pain bothersomeness scale.
  • Specific diseases or pathologies identified as the cause of back pain, including the conditions listed in the study protocol.
  • Previous vertebral column or back surgery.
  • Disabling chronic conditions that may confound treatment effects or interpretation of the data.
  • Contraindications to acupuncture or situations in which its safety has not been confirmed, including clotting disorders, anticoagulant therapy, a cardiac pacemaker, pregnancy or seizure disorder.
  • Deemed unfit for acupuncture and/or robotic Tuina by the treating Chinese medicine physician because of the participant's current medical condition.
  • Current use of long-term medication for pain management and relief, as specified in the study protocol.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Acupuncture Plus Automated Robotic Tuina

Standard acupuncture treatment followed by Automated Robotic Tuina

Participants receive 30 minute standard acupuncture and automated robotic Tuina using the EMMA device, according to the study's standardized operating procedures. Robotic Tuina is applied to the lumbosacral region, hips and lower limbs. The protocol describes an approximately 30-minute robotic Tuina treatment, with the applied force adjusted according to participant feedback within the specified range.

Aktiver Komparator: Acupuncture alone

Standard acupuncture

Participants receive acupuncture according to the study's standardized treatment protocol. The protocol describes needle retention for 30 minutes and specifies the acupuncture points and procedures to be used.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change from baseline in pain intensity. Visual analogue scale.
Zeitfenster: At baseline, at 8 weeks

A 10-point Numerical Pain Scale (0: no pain, 10: maximum pain) assesses the intensity of pain

At baseline, at 8 weeks

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change from baseline in Roland Morris Disability Questionnaire (RMDQ).
Zeitfenster: At baseline and at 8 weeks

This is a self-reported questionnaire consisting in 24 items reflecting limitations in different activities of daily living attributed to low back pain including walking, vending over, sitting, lying down, dressing, sleeping, self-care and daily activities.

At baseline and at 8 weeks
Change from baseline in Brief Pain Inventory (BPI)
Zeitfenster: At baseline and at 8 weeks

Pain interference was evaluated using the Pain Interference subscale of the Brief Pain Inventory (BPI). The subscale consists of 7 items assessing how much pain disrupts dimensions of daily living. Each item is scored on a 0 to 10 numeric rating scale. The overall score is calculated as the mean of the 7 items, yielding a final score ranging from a minimum of 0 to a maximum of 10. A higher score indicates a worse outcome (greater pain interference with daily functioning).

At baseline and at 8 weeks
Change from baseline in WHO-QOL (Brief)
Zeitfenster: At baseline and at 8 weeks

Quality of life was evaluated using the World Health Organization Quality of Life-BREF (WHOQOL-BREF). The scale comprises 26 items assessing 4 domains: Physical Health (7 items), Psychological (6 items), Social Relationships (3 items), and Environment (8 items). Domain scores are calculated by summing the respective items and converting them to a transformed scale. For each domain, scores range from a minimum of 0 to a maximum of 100, where a higher score indicates a better outcome (higher quality of life)

At baseline and at 8 weeks
Change in objective sleep parameters via wearable smart ring
Zeitfenster: At baseline throughout the 8 weeks, to be tracked the night before and after treatment session.

Assessed using Leadtek smart ring worn on the finger. Evaluated parameters include sleep time, overnight heart rate variability and sleep quality from baseline to week 8

At baseline throughout the 8 weeks, to be tracked the night before and after treatment session.
Change in Technology Acceptance Model (TAM) questionnaire from baseline
Zeitfenster: At baseline and at 8 weeks

Participant acceptance of automated robotic Tuina, will be measured at baseline and after completion of study covering domains including perceieved usefulness, attitude and behavioural intentions. A 7-point Likert scale was used to measure TAM constructs, where 1 indicated 'strongly disagree' and 7 indicated ' strongly agree'. A higher score reflects better perception of and attitutude towards the technology.

At baseline and at 8 weeks
Incidence of Treatment-Emergent Adverse Events [Safety]
Zeitfenster: From start of treatment to end of treatment at week 8

Incidence and nature of adverse events during the study.

From start of treatment to end of treatment at week 8

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Mitarbeiter

Ermittler

  • Hauptermittler: Linda Zhong, Associate Professor, Nanyang Technological University

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. Januar 2025

Primärer Abschluss (Geschätzt)

30. Dezember 2027

Studienabschluss (Geschätzt)

30. Dezember 2027

Studienanmeldedaten

Zuerst eingereicht

29. Oktober 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

15. November 2026

Zuerst gepostet (Tatsächlich)

18. November 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

18. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

15. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Zusätzliche relevante MeSH-Bedingungen

Andere Studien-ID-Nummern

  • IRB-2023-1071

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

Individual participant data will not be made available to external researchers. Participant-level data contain confidential health information and will be managed in accordance with the approved study protocol, informed consent requirements, institutional policies and applicable data-protection requirements. Study findings will be disseminated through appropriate scientific publications and other research outputs.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .